Sudo Katsumi
- Articles
- Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice.
Sudo Katsumi
Journal of Cardiovascular Phamacology/44(S1)/pp.S479-S482, 2004 - A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats.
Sudo Katsumi
Vascular Pharmacology/43(1)/pp.40-46, 2005 - A Novel Vasopressin Dual V1A/V2 Receptor Antagonist, Conivaptan Hydrochloride, Improves Hyponatremia in Rats with Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH).
Sudo Katsumi
Biological Pharmaceutical Bulletin/30(1)/pp.91-95, 2007 - Vasopressin receptor antagonists: potential indications and clinical results.
Sudo Katsumi
Current Opinion in Pharmacology/7(2)/pp.124-129, 2007 - An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan Protects Against Neurological Deficits and Prolongs Survival in Spontaneously Hypertensive Rats Stroke-Prone (SHR-SP) Infused with Ang II
Sudo Katsumi
Vascular Disease Prevention/4(2)/pp.151-154, 2007 - The Effects of Endothelin-1 and YM598, a Novel Selective Endothelin Eta Receptor Antagonist, on the Lower Urinary Tract in Vitro (Rabbit Tissue) and in Vivo (Dogs)
Sudo Katsumi
The Journal of Urology/173(4S)/pp.392-392, 2005 - In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract.
Sudo Katsumi
European Journal of Pharmacology/580(3)/pp.394-400, 2008
- Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice.